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ABSTRACT Continuous glucose monitoring systems (CGMSs) allow measuring the blood glycaemic value
of a diabetic patient at a high sampling rate, producing a considerable amount of data. These data can
be effectively used by machine learning techniques to infer future values of the glycaemic concentration,
allowing the early prevention of dangerous hyperglycaemic or hypoglycaemic states and better optimization
of the diabetic treatment. Most of the approaches in the literature learn a prediction model from the past
samples of the same patient, which needs extensive calibrations and limits the usability of the system. In this
paper, we investigate the prediction models trained on glucose signals of a large and heterogeneous cohort
of patients and then applied to infer future glucose-level values on a completely new patient. To achieve this
purpose, we designed and compared two different types of solutions that were proved successful in many
time-series prediction problems based respectively, on non-linear autoregressive (NAR) neural network and
on long short-term memory (LSTM) networks. These solutions were experimentally compared with three
literature approaches, respectively, based on feed-forward neural networks (FNNs), autoregressive (AR)
models, and recurrent neural networks (RNN). While the NAR obtained good prediction accuracy only for
short-term predictions (i.e., with prediction horizon within 30 min), the LSTM obtained extremely good
performance both for short- and long-term glucose-level inference (60 min and more), overcoming all the
other methods in terms of correlation between the measured and the predicted glucose signal and in terms
of clinical outcome.
INDEX TERMS Continuous glucose monitoring, diabetes, non-linear autoregressive neural network, long
short-term memory (LSTM) network, time-series analysis, machine learning.
I. INTRODUCTION
The human body, through the appropriate organs, breaks
down carbohydrates into glucose. Insulin, a peptide hormone
produced by beta cells of the pancreatic islets, plays a key role
in this process, regulating the way the cells absorb glucose
and use it as an energy source [1]. Defects in either insulin
secretion or insulin sensitivity (or both) lead to diabetes, that
is a chronic disease characterized by high glucose levels in
the blood (i.e. hyperglycaemia) [2]. This is a severe condition,
that is known to at least double a person’s risk of early death.
Diabetes can be categorized into three main categories.
Type I diabetes, that affects about 10% of the diabetic
The associate editor coordinating the review of this manuscript and
approving it for publication was Mauro Tucci.
patients, usually develops since childhood due to a loss of beta
cells, that are mistakenly attacked and killed by the immune
system [3], [4], resulting in a loss of insulin. Type II diabetes
occurs when the body does not make a proper use of the
released insulin (i.e. insulin insensitivity) or does not produce
enough insulin [5]. This is the most common form of diabetes
(about 90% of the diabetic population [3]) and usually devel-
ops in adulthood. Gestational diabetes, a temporary condition
occurring only during pregnancy, affects between 3 and 20%
of mothers-to-be, with increased risks of developing future
chronic diabetes for both mother and child [6].
Diabetes in all its forms is among the most widely diffused
chronic disorders worldwide, with ever-increasing diffusion
trends in both women and men. Hence, there are growing
efforts directed towards the development of therapies as well
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as of better ways of keeping the effects of this disease under
control. In this work, we focus especially on Type I diabetes.
Nonetheless, our study can be easily generalized to the other
forms of the pathology.
In a normal subject, glycaemia typically oscillates between
70 − 100 mg/dl in a fasting state and does not exceed
140 mg/dl after a meal. Conversely, diabetic subjects have
fasting values higher than 126 mg/dl, and may encounter
either hyperglycaemia (when the glycaemic value in the blood
exceeds 180 − 200 mg/dl) or hypoglycaemia (when the
glycaemic value is much lower than 70 mg/dl), that are both
life-endangering situations. Such events need to be timely
detected, in order to take all possible countermeasures to save
the patient’s life.
Traditionally, diabetic patients are monitored bymeasuring
their glycaemic value multiple times in a day (four or more,
for a Type I diabetes) using a fingerstick blood glucose meter,
often accompanied by fixed insulin infusions. This type of
monitoring has a major disadvantage, in that it cannot detect
fluctuations of the glycaemia that may be caused by intense
physical activity, sudden emotional stress or food assumption.
As a result, insulin injections are often over- or under-dosage
with respect to the actual need [7].
Today, thanks to the widespread use of increasingly intelli-
gent and low-cost technological devices, the medical sector is
moving more and more towards the concept of smart health-
care [8]. In this scenario, diabetic patients, especially Type I,
are subjected to constant monitoring and appropriate and
timely insulin treatment, by means of Continuous Glucose
Monitoring Systems (CGMS) [9]. Using sensors applied to
the skin, CGMS are able to measure the glycaemic value
of a subject at a rate of up to one sample per minute. This
generates a considerable amount of data that can be either
stored or sent to a processing system, and used to infer the
future values of glycaemic concentration within different pre-
diction horizons, with a two-fold benefit: i) better prevention
of potentially dangerous hyperglycaemic or hypoglycaemic
states and ii) optimization of the insulin dose that needs to be
injected [10]. On top of that, the patient can be subjected to
a continuous remote monitoring by the primary care physi-
cians, triggering automatic alert mechanisms and, whenever
needed, faster hospitalization procedures [11], [12].
Since the introduction of CGMS, literature has proposed
several approaches for short-time glucose prediction, that can
be broadly categorized into two main groups: i) approaches
based on a priori physiological models, that try to reproduce
the metabolic response of a patient by means of equations
that mathematically describe glucose kinetics [13], [14];
ii) data-driven approaches [15], [16], that infer the future
values of glucose concentration by applying machine learn-
ing techniques trained on real glycaemic data (see [17]
for a review of some recent methods). As they do not
depend on fixed parameters, machine learning techniques
promise higher flexibility and generalization capability of a
fixed physiological model, especially in presence of unpre-
dictable variability of glucose kinetics due to either internal
(e.g. different device calibrations) or external factors
(e.g. physical activities, food intake, sudden stress, etc.).
Hence, thanks to the higher availability of data, the data-
driven approaches are generally preferred in the last few
years.
In this paper, we propose a blood glucose prediction system
exploiting the data-driven approach.
In the following, we first review the literature of
data-driven glucose prediction, highlighting the limitations
of the available techniques. Then, we introduce the main
contributions of our work.
A. RELATED WORK
The idea of predicting the future trend of glucose level by
using its past values as the only input was first exploited
in [18] and then refined in most recent years, taking advan-
tage of more powerful and accurate data recording devices
and more sophisticated machine learning models. The most
frequent approaches provided by literature are either based
on time-series autoregressive models (AR) or artificial neural
networks (ANN) [17]. In [19], a first-order AR model is
proposed and compared with a first-order polynomial model.
In the same years, a method based on Kalman filtering is used
to predict hypoglycaemic events [20] based on glucose mon-
itoring signal. Nonetheless, these methods have still signifi-
cant prediction errors and a very limited forecasting window
(maximum 45 and 30 min, respectively). In [21], [22], ANN
approaches were used to predict glycaemia up to 3 hours.
Nonetheless, the accuracy of the prediction considerably
decreases when the prediction horizon increases. Better accu-
racy values, albeit on different test sets, were shown by the
most recent works, either based on ANN or on support vector
regression techniques [23]–[26]. A common trait of these
works is that they are usually calibrated on individual patients
(i.e. the prediction for a certain patient is built on top of the
past glucose level signal recorded from the same patient).
While this approach has the obvious advantage of creating a
personalized model that perfectly fits the characteristics of a
specific patient and of a recording device, it has also multiple
disadvantages: i) it limits the usability of the device, in that
the system cannot be used on a patient until the calibration is
fully performed, ii) it limits the generalization capabilities of
the system and increases the risks of overfitting. Conversely,
learning a model from a heterogeneous set of patients and
recording devices increases in principle the robustness of
the model to unpredictable and unseen changes of the input
signal [27]. On top of that, the device can be used on a new
patient immediately, without re-training.
Fewer studies in literature explored the idea of creat-
ing a generalizable glucose level prediction model from a
multi-patient training cohort. In [28], [29] the authors propose
an AR model with fixed coefficients (applying data filtering
and Tikhonov regularization [30]) and compare three differ-
ent configurations: respectively i) models trained on each
individual subject, ii) a model trained on different subjects
using the same CGMS device, and iii) a model trained on
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different subjects using different devices. Their experimen-
tal results show comparable prediction errors for the three
scenarios on a forecasting horizon of 30 min. Further devel-
opments of the same idea are presented by [31], this time
usingmodel based on feed-forwardANN, and by [32], using a
recurrent neural network (RNN). Nonetheless, the forecasting
accuracy obtained by these works is still modest, and the
data used for the training is poor both in terms of number
and type of patients (e.g. age categories), which intrinsically
limits their generalization capability.
While the most consolidated works are generally based on
shallow neural networks, few recent studies started proposing
deep learning techniques [16], [33], [34] (e.g. Convolutional
Neural Networks). Nonetheless, these methods are typically
very demanding, both in terms of training data and com-
putational resources. Hence, the proposed predictors suffer
limitations due to the lack of annotated CGM signals used
for training the networks, both in terms of number and type
of patients considered in the analysis, as well as type of
recording devices.
B. CONTRIBUTIONS
In this work, we continue on the path of learning a model
from a multi-patient dataset and using this model to predict
the future glucose level values of a new patient. By doing so,
we try to improve the previous works in two ways: i) by refin-
ing the formulation of the neural network used for the pre-
diction; and ii) by considerably enlarging the dataset used
for learning the model. The aim is to improve the prediction
accuracy, possibly on a much larger forecasting horizon, and
to increase the generalization and robustness of the model.
As of point i), we designed and compared two dif-
ferent solutions, that were successfully applied to other
time-series forecasting problems. The first solution exploits
a Non-Linear Autoregressive Neural Network (NAR). This
model extends and refines traditional linear AR architectures,
in that it is not intrinsically limited by the assumption of
linearity, and overcomes the stability problems of past formu-
lations [35]. The second solution exploits a Long Short-Term
Memory (LSTM) network, that is generally acknowledged as
one of the best for time series prediction, thanks to its versa-
tility and flexibility [36], [37]. This model is able to overcome
the well-known problems of exploding and vanishing gradi-
ent that typically affect traditional RNN architectures, and to
maintain long-term information over time [38], [39]. While,
to the best of our knowledge, NAR was never applied before
to the problem of glucose profile prediction, few recent works
exploited LSTM, eventually embedded into deep learning
frameworks [33], [34], [40]. These works show promising
results of LSTM model compared to other approaches, but
they are still limited by lack of training data.
As of point ii), we trained and tested our new solutions
on a very large set of CGMS signals, with unprecedented
variability both in terms of type of subjects and recording
devices. This choice stems from the consideration that a
higher variability of the training set is known to improve
the generalization capabilities of the prediction model and to
reduce the risks of over-fitting.
To evaluate the forecasting accuracy and robustness of
our solutions, we assessed our results in comparison with
other multi-patient techniques, exploiting traditional AR,
feed-forward ANN and RNN formulations, respectively. For
a fair comparison, we re-implemented the architectures pro-
posed by previous works [29], [31], [32] and performed
experiments on the same dataset as our proposed solutions,
both for training and testing purposes.
II. DATASET
In the following, we describe in details the dataset that we
used to train and test our prediction system.
As anticipated in Section I, our aim is a generalizable
CGMS, that learns a prediction model from a fixed set of
subjects and then is able to predict glucose level values on
a new patient without needing any re-calibration. To do so,
the system needs to be trained on a large set of CMGS signals,
possibly representing a verywide range of possible outcomes.
This inherently reduces the risks of learning a model that is
too simple or unfit to deal with unseen data.More specifically,
the training set should represent wide variations of glucose
dynamics and reflect differences due to either different sub-
ject categories (e.g. adults and children, female and male,
etc.) or different recording systems. On top of that, to ensure a
good representation of glucose dynamics the training samples
should be acquired on a continuous basis for a sufficiently
long monitoring period, with a rate that is high enough to rep-
resent glycaemic fluctuations. Supported by past literature,
we identified 5 min as the minimum sampling rate for the
CGMS (lower frequency is acceptable only during sleeping
time, when the signal is less subject to fluctuations), two days
as the minimum monitoring time per subject and 30 samples
as the minimum length of a monitoring sequence for it to be
considered significant [41], [42].
Based on the considerations above, we decided to use the
RT_CGM dataset [43], that is freely available for research
purposes, in anonymized form in order to protect patients’
privacy. This dataset includes glycaemia trends of an het-
erogeneous population of 451 patients affected by Type I
diabetes, already randomized. Patients have different ethnic
origins and gender (45% male and 55% female, respec-
tively), and belong to three different age categories (respec-
tively, adults > 25, adolescents and young adults 15 − 24
and children 8 − 14). The data consist in glucose level
samples acquired every 5 min using three different CGMS
devices (provided by Abbott Diabetes [44], DexCom [45] and
Medtronic [46], respectively). On top of that, patients take
insulin in two different ways, either by injections or using a
micropump delivery system.
The original dataset was pre-processed to make it con-
sistent for our analysis. More specifically, we removed
sequences with too many gaps as well as sequences with
less than 30 consecutive samples, due to device calibration
or measurement errors. Then, we randomly split the resulting
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FIGURE 1. Main phases of the study.
data into two sub-sets for training and testing purposes, con-
taining about 70% and 30% of the initial samples, respec-
tively. The full characterization of these two sets is reported
in Table 1. The training and test sets are completely indepen-
dent in terms of patients (i.e. data from a certain patient can
be either in training or on the test set).
TABLE 1. Dataset characterization.
The training set was used to train the predictionmodels and
optimise their parameters, using a portion of the samples as
validation set, whilst the test set was solely used for assessing
the final prediction performance.
III. METHODOLOGY
In Figure 1, we show the main phases of our study. In the
so-called training phase, training samples first undergo a
pre-processing filtering step. The filtered data are used as
input to build a prediction model, either based on NAR or
LSTM neural networks. In the test phase, new unseen and
unfiltered data are fed into the trained models to obtain
the final predictions. All the implementations were done in
Matlab (NNSYSID toolbox) and Python, using TensorFlow
as back-end and exploiting Scikit-learn, pyrenn and pandas
libraries.
In the following, we describe in details the main phases of
the system.
A. PRE-PROCESSING
Generally, CGMS sensors introduce some amount of noise
during signal sampling [42], [47], that needs to be attenuated
or removed before the data can be used either to train a pre-
diction system or to infer new values from unseen data [48].
As it is well known from literature, over-smoothing the glu-
cose time series data translates into a higher risk of missing
out hypoglycaemia and hyperglycaemia events. On the other
hand, processing the data completely unfiltered might lead
to false alarms caused by few unexpected sensing errors [48].
Hence, data filtering should be performed having as objective
a reasonable compromise between these two opposite effects.
As a denoising pre-processing step, we applied to the
training data Tikhonov regularization [49], that is widely used
in time series analysis and in glucose level prediction system.
As demonstrated by [28], [29], this method allows to obtain a
filtered version of the signal without introducing significant
delays into the time series.
Tikhonov is a filtering technique, where the N-dimensional
filtered signal yˆ (N = 30 in our case) is obtained as follows:
yˆ = Udω, (1)
where ω is the N -dimensional first derivative of the input
signal and Ud is the N × N integral operator matrix:
Ud =

1 0 0 · · · 0 0 0
1 1 0 · · · 0 0 0
1 1 1 · · · 0 0 0
...
...
...
...
...
...
...
1 1 1 · · · 1 0 0
1 1 1 · · · 1 1 0
1 1 1 · · · 1 1 1

(2)
To estimate ω, we need to minimize the functional f (ω):
f (ω) =‖ y− Udω ‖2 +λ2d ‖ Ldω ‖2, (3)
where y is the N -dimensional input glucose time series, Ld is
the second derivative operator matrix, as in [50], and λd is
a regularization parameter, set to 3000 following the imple-
mentation of [28].
Then, we formulated Tikhonov regularization as an explicit
functional minimization problem, as follows:
yˆ = (UTd Ud + λdLTd Ld )−1UTd y (4)
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FIGURE 2. Effects of Tikhonov regularization on glucose level data:
Example.
In Figure 2, we show an example of the effect of Tikhonov
regularization applied to our CGMS training data. As it can
be easily gathered from the plot, the filter attenuates sudden
spikes in the signal, without altering the trend and without
introducing delays, as already demonstrated by [28], [29].
B. PREDICTION MODEL BUILDING
In the following, we present our glucose prediction models
based on NAR and LSTM neural networks, respectively.
More specifically, for both the solutions we describe i) how
we selected and identified the final architecture and related
parameters of the predictionmodels and ii) howwe optimized
such parameters in order to boost the performance and robust-
ness of the models, preventing the risk of over-fitting.
1) NON-LINEAR AUTOREGRESSIVE (NAR)
NEURAL NETWORK
As anticipated in Section I, Non-Linear Autoregressive
(NAR) extends traditional linear autoregressive model [51],
in that it is completely distribution-free. Hence, it can be
applied even to time series with intrinsic non-linearities, such
as sudden spikes and fleeting transient periods [52].
A NAR model computes the value of a signal y at time t
using n past values of y as regressors (also called feedback
delays), as follows:
y(t) = f (y(t − 1), y(t − 2), ..., y(t − n))+ e(t), (5)
where f is an unknown non-linear function and e(t) is the
model approximation error at the time t .
Function f (·) is computed by optimizing a multi-layered
neural network, whose topology is depicted in Figure 3(a).
At the time t , the neural network is fed with the n past
values of the signal y. Such inputs are transferred through
multiple layers of neurons, where each neuron is a simple
computational unit characterized by a set of weights W (one
per each input connection j), a bias b and an activation func-
tion h. Hence, the output of a neuron i is computed as follows:
outi = hi
∑
j
wi,j · ini,j + bi
 (6)
where the optimal values of wi,j and bi are computed by
back-propagation on the training set [52].
As anticipated in Section II, the minimum number of con-
secutive samples in our dataset is 30. Keeping this in mind,
we initially designed a very simple fully-connected NAR as
the one represented in Figure 3, with the following topology:
1) one input layer, with 30 units;
2) one hidden layer, again with 30 units;
3) one output layer, with one unit.
As reported in Figure 3(b), we used hyperbolic tangent
activation functions for the hidden units and a linear activa-
tion function for the output unit.
As a learning paradigm for the NAR network, we imple-
mented a Levenberg-Marquardt backpropagation procedure
(LMBP), which is widely applied to NAR models. This
technique approximates second-order derivatives leveraging
a trust region approach [52], with no need to compute the
Hessian matrix. This helps reducing the training speed com-
pared to traditional backpropagation techniques.
As it is widely known, models with too many parame-
ters (i.e. too many neurons and connections) are less fit for
hardware implementation and may easily lead to over-fitting.
To overcome this problem, we adopted a two-steps design
procedure, as follows:
1) we applied an automated optimization strategy based
on Lipschitzmethod [53] to possibly reduce the number
of regressors of our model (i.e. the number of past
glucose values to be given as input to the system).
2) we performed an automated pruning of the initial
fully-connected structure, based on Optimal Brain Sur-
geon (OBS) method [54].
This two-steps procedure allowed us to design a more com-
pact version of the network compared to the one of Fig-
ure 3(a), obtaining a non-redundant NARmodel with optimal
number of inputs and computational units.
As of point 1), we applied Lipschitzmethodology for deter-
mining the optimum lag-space, that in our case is the number
of delayed glucose signals to be used as regressors [53]. This
method is successfully used for the analysis of Input-Output
Models orders in Non-linear Dynamic Systems in many
applications. As initially proposed by He and Asada [55],
a reliable decision on the optimal order n of a non-linear
model characterized by training input-output pairs (xi, yi) can
be made based on so-called Lipschitz quotients:
q(n)i,j =
|yi − yj|
‖xi − xj‖ , (7)
where in our case xi is a vector of inputs and yi is the
corresponding output of the system, with i 6= j and i, j = 1..N
where N is the number of samples in the training set. Hence,
the superscript n stands here for the number of regressors of
the system.
Lipschitz order index L(n) is defined as the geometric mean
of the m largest Lipschitz quotients, as follows:
L(n) =
[
m∏
k=1
√
n · l(n)(k)
] 1
m
, (8)
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FIGURE 3. Non-linear autoregressive neural network. (a) Network topology. (b) Neuron models of the input,
hidden and output layers, respectively.
where m is a positive number recommended to be ∼ 0.01N
and l(n)(k) is the k-th largest Lipschitz quotient among all q(n)i,j .
Finally, as demonstrated by [55], the optimal number of
regressors can be found by plotting Lipschitz order index
at increasing values of n, in a forward sequential way, and
selecting the knee-points of the obtained curve. As reported
in Figure 4, by applying this procedure to our training data,
we found n = 8 and n = 17 as the best candidates for the
number of regressors of our system.
FIGURE 4. Evaluation of order index criterion for different lag-space.
Based on Lipschitz results, we implemented three
fully-connected NARmodels, respectively with 30 (that is the
minimum number of consecutive samples of our dataset, and
hence the upper-bound of the input size), 17 and 8 regressors.
These three models were trained on the training set described
in Section II, using LMBP as the learning algorithm. To assess
the goodness of the training and the generalization capa-
bilities of the three models after this first design phase,
in the second column of Table 2 we report the normalized
sum of squared errors (nSSE) obtained after training the 30,
17 and 8 regressors models, respectively. These values were
computed on a portion of the training set solely used for
validation and optimization purposes. (i.e. validation set).
As it can be easily gathered from the table, the model with
8 regressors is the one obtaining the best performance.
As of point 2) of our two-steps design procedure, each of
the fully-connected models obtained after Lipschitz under-
went automated pruning. The objective of this second design
phase is to eliminate redundant connections between the
neurons, and hence obtain more efficient and compact mod-
els than the initial ones, possibly improving or at least not
impacting on their prediction capability. For this purpose,
we implemented an Optimal Brain Surgeon (OBS) method-
ology, as first introduced by [54]. The main idea behind this
procedure is to estimate the increase in the training error when
deleting weights, leveraging information in the second-order
derivatives of the error surface.More specifically, the strategy
works towards the minimization of the error variation, lever-
aging a recursive calculation of the inverse Hessian matrix
from the training data to obtain better approximations of the
error function (see [54] for details). This strategy has been
demonstrated to eliminate more redundant neuron connec-
tions than other pruning techniques, yielding to models with
improved generalization capabilities [56].
The three pruned models (respectively with 30, 17 and
8 regressors) were trained again with a Levenberg-Marquardt
backpropagation procedure (LMBP). The nSSE values
obtained after this second round of training are reported in
the third column of Table 2.
From the analysis of this table, we can see that OBS prun-
ing further reduced the validation error of the three models.
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TABLE 2. Validation error (nSSE) before and after OBS pruning.
As it was reasonable to expect, the model that benefited
the most from the pruning is the 30 regressors one. On the
other hand, the 8 regressors NAR is the one that had the best
compromise between generalization error (that is comparable
with the one obtained by the 30 regressors after pruning) and
simplicity of the model, which guarantees the lowest risks
of over-fitting. Based on these considerations, we decided to
select the pruned network with 8 regressors as the final NAR
model for glucose level predictions. The architecture of this
model is schematically represented in Figure 5.
FIGURE 5. NAR final architecture.
2) LONG SHORT-TERM MEMORY NEURAL NETWORK
The Long Short Term Memory networks (LSTM) repre-
sent an evolution of the classic Recurrent Neural Networks
(RNNs).
Unlike Feed-Forward models, where the information flows
just in one direction (from the input to the output) and each
layer is characterized by a different set of parameters, RNN
models are characterized by multiple layers of recurrent units
all sharing the same parameters, with loops allowing the
information to propagate back to the same computational
units (see the diagram in Figure 6). By doing so, each com-
putational step takes into account not only the current input
at time t , but also what was learnt from the previous inputs.
Ultimately, this makes it particularly suitable for time-series
predictions [57].
A well-known limitation of classic RNN architectures,
where the parameters of a large number of layers are learnt
by backpropagation, is the instability of long-term predictions
due to either vanishing or exploding gradient problems [58].
Such problems arise during the training of a deep network,
when the error gradients are propagated back in time to the
initial layer, going through continuousmatrixmultiplications.
As the gradients approach the earlier layers, if they have small
FIGURE 6. Unfolding of a recurrent neural network unit. xt is the input at
time step t , st the hidden state, also called memory of the network
(initialized to 0), f is a non-linear activation function and ot the output.
values (much lower than 1), they shrink exponentially until
they vanish, making it impossible for the model to learn.
Likewise, very large gradient values (much greater than 1) get
larger and larger and eventually crash the model.
LSTM modules are specifically designed to overcome this
limitation [59]. While the structure of the network is funda-
mentally very similar to RNN, a different function is used to
compute the hidden state [60]. In the RNN, repeatingmodules
consist of a single layer, typically with tangential activation
function. The memory in LSTMs is instead implemented as
cells (see Figure 7), where specific gating functions decide
whether the information needs to be kept or erased from
memory at each time step. The key to this process is the
cell state (in the diagram of Figure 7, the green horizontal
line), which conveys information to the next cell. The power
of either removing or adding information to the cell state
is regulated by gates (respectively, input, output and forget
gates) consisting of sigmoidal activation functions coupled
with pointwise multipliers. Each sigmoid outputs values in
a 0 to 1 range, modulating how much of the corresponding
signal should be let through (for more details, see [60]).
No matter how deep the network is, the LSTM network will
be able to remember values that are passed through gates all
in 1 state. This makes the LSTM model intrinsically immune
to vanishing and exploding gradient.
For our specific problem of glucose level prediction,
we designed a LSTM network consisting of a layer
of 30 LSTM units and a single output layer (dense), with a
number of units equal to the future glucose samples that need
to be predicted (i.e. 18, corresponding to a 90 min prediction
horizon at a 5min sampling rate). The architecture of the cells
is the same that is depicted in Figure 7, consisting of input,
forget and output gates with sigmoidal gating functions.
As we did for the NAR module, before deciding the final
architecture of the LSTM model, we investigated the possi-
bility of reducing the number of cells of the network as well
as the number of past glucose levels to be used as regressors
for the prediction. We run experiments with respectively 30
(our upper bound), 17 and 8 regressors, that represent the
knee-points detected applying Lipschitz order index method
to our training data (see Figure 4). In Figure 8, we show values
of the validation error, in the form of Root Mean Square Error
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FIGURE 7. LSTM diagram, where xt is the input and ht is the output of a cell.
FIGURE 8. Validation error (RMSE) of LSTM models.
on the validation set, obtained by the 30, 17 and 8 regressors
models, at increasing time prediction windows (respectively
from a minimum of 30 up to a maximum of 90 min). As it is
clear from the plot, the 30 regressors model is the one with
the best performance. As expected, for all the models the
prediction error increases exponentially with the prediction
window. The 8 regressors model is consistently the one with
the lowest prediction accuracy.
In general, the 30 regressors model is the one that provides
the best performance for either short-time and long-time
glucose level predictions.
To optimise the hyper-parameters of our network and pre-
vent either under-fitting or over-fitting problems, we imple-
mented a training procedure imposing an initial learning
rate equal to 0.001, with dropout. More specifically, at each
training stage individual nodes and corresponding links are
randomly dropped out of the model, leaving a reduced
network [61]. This regularization procedure helps reduc-
ing co-dependency of parameters, and hence prevents over-
fitting. Then, we chose Adam (Adaptive moment estimation)
as the optimizer. This algorithm leverages adaptive learning
rates methods to set individual learning rates per each param-
eter, combining this feature with the advantages of classical
optimization techniques such as stochastic gradient descent
and root mean square propagation. This technique was
demonstrated to be particularly suitable for non-stationary
problems with lot of noise [62].
The training steps for the learning procedure were set to
50000, with a batch size of 100. In order to keep the compu-
tational costs of the training under control without having to
reduce the size of the training set, we implemented a mini-
batch training paradigm. More specifically, the training set
was split into a number of small sub-sets of size 100, that
were used to compute the model error. Each mini-batch was
computed in parallel during each iteration. Then, the average
error over the mini-batches was used to update the model
parameters at each iteration. This method, besides consid-
erably reducing computational time and memory require-
ments, has been demonstrated to generally improve themodel
performance [62].
To find a good compromise between a learning rate too low
(which may make the training too slow) or too high (which
may lead to sub-optimal solutions), we imposed a step decay
schedule, that dropped the initial learning rate by a 0.9 factor
every 1000 iterations.
After running the learning algorithm on the training set,
the so-obtained LSTM model was used as-is to predict glu-
cose level values on an independent test set, with prediction
horizons spanning from 30 up to 90 min.
IV. EXPERIMENTAL RESULTS
In the following, we present and discuss the experiments that
were performed to assess the prediction models described in
Section III. To obtain a thorough evaluation of our methods,
our analysis was divided into two main parts:
1) analytical assessment. In this part, we assess the valid-
ity of the predictions from a regression analysis point
of view, by computing a set of metrics that are widely
used to quantify the similarity of a discrete time-series
with a reference ground truth;
2) clinical assessment. In this part, we assess the valid-
ity of the predictions from a clinical point of view.
To do so, we use metrics that are specifically designed
to validate the clinical outcome of blood glucose
measurements.
Both the assessments were performed on a test set (fully
characterized in Section II) that is completely independent
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from the one that was used to design, train and optimise the
prediction models.
To evaluate the performance of our models, the results
obtained by our solutions were compared with the results
obtained by literature techniques. As already anticipated
in Section I, the most prominent multi-patient data-driven
prediction techniques are based either on autoregressive
models (AR), dense feed-forward neural networks (FNN)
or standard recurrent neural networks (RNN). Even though
most of the works provide a quantitative assessment of these
methods, a fair comparison requires that all the predictors
are trained and tested on the same data. Hence, we re-
implemented three state of the art glucose predictors based
respectively on AR, FNN and RNN, strictly following the
design reported in the respective publications [29], [31]
and [32]. Then, we trained, optimized and tested the three
models on our data, with the same procedure that was applied
to our proposed solutions.
The experiments were run on a Linux computer equipped
with an Intel R© CoreTM i7-8750H CPU with 2.20 GHz,
6 cores, 12 logical processors and 16,0 GB of installed Phys-
ical Memory.
A. ANALYTICAL ASSESSMENT
To evaluate the prediction accuracy of the models,
we exploited a number of metrics that are widely used in
descriptive statistics and in regression analysis to quantify the
similarity between predicted and observed time-series. More
specifically we focused on a list of metrics that are more often
used by blood glucose level predictions literature [63]:
• RMSE is the Root Mean Square Error, defined as the
standard deviation of the difference between the pre-
dicted and the observed values. It is the prediction error
index that is most often used in literature.
• R2 is theCoefficient of Determination, defined as square
of the correlation (R) between predicted and observed
values. Thus, it ranges from 0 (absence of correlation)
to 1 (complete correlation).
• Time lag is the Prediction Delay, defined as mini-
mum time-shift between the predicted and observed sig-
nals which provides the highest correlation coefficient
between them.
• MAD is the Mean Absolute Difference between pre-
dicted and observed values.
• FIT is computed as the ratio of RMSE and the root mean
square difference between the observed signal and its
mean value, as reported in the following equation:
FIT =
1−
√
1
N
∑
(Y − Yˆ )2√
1
N
∑
(Y − Y¯ )2
 · 100, (9)
where Y and Yˆ are respectively the observed and pre-
dicted signals and Y¯ is the mean value of the observed
signal. FIT closer to 100% indicates better prediction
accuracy.
Before assessing the prediction accuracy of the mod-
els in comparison with literature approaches, we run few
preliminary experiments to demonstrate the goodness of
the pre-processing stage based on Tikhonov regularization
applied to the training data (see Section III-A).
In the plot of Figure 9, we report the results of these
experiments. More specifically, we plot the RMSE values
obtained by both the NAR and LSTM prediction models on
the test dataset, with different prediction horizons (from 30 up
to 90 min with steps of 15). The same experiments were
performed training the models first on raw data and then on
filtered data. In both cases, the testing was performed on the
raw unfiltered data, as specified in the diagram of Figure 1.
FIGURE 9. Impact of training data filtering on NAR and LSTM models
predictions.
As it is clearly visible from the plot, the filtering signif-
icantly decreased the prediction error of both the models,
with special benefit for LSTM model. On top of that, we can
observe that the error trend against prediction horizon was
more or less the same with or without filtering.
In Table 3, we report the values obtained running all the
prediction models on the same test set, with our proposed
NAR and LSTM networks highlighted in grey and light blue,
respectively. Each sub-section of the table shows the values of
all the figures of merit defined at the beginning of the section.
Different columns show values obtained at different predic-
tion horizons, starting from 30 min (short-term prediction)
up to 90 min (very long-term prediction), at steps of 15 min.
For completeness, we show on the left the performance of
the models trained on raw data and on the right the values
obtained by the same models trained on filtered data and
validated on the unfiltered ones.
From the values of Table 3, we can draw the following
considerations:
• All the models benefited from pre-processing the train-
ing data with Tikhonov. Hence, from now on we will
mainly focus on the analysis of this set of experiments.
• the LSTM model is by far the one that obtained the
best prediction performance. This is consistently con-
firmed by all the figures of merit, for both short-term
and long-term predictions. Remarkably, the time-lag
observed for this model was zero until a prediction hori-
zon of 60min. On the contrary, all the other models had a
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TABLE 3. Prediction performance indicators for all the tested models.
time-lag of 3 samples (15 min) at best for the short-term
horizon.
• FNN is the model with the worst performance. On top of
that, it is the one presenting the most rapid decrease of
prediction accuracy when increasing the prediction hori-
zon. The time lag is especially high, reaching 14 samples
for long-term predictions.
• NAR, AR and RNNmethods seem to have a comparable
behavior, especially for short-term predictions.
• When comparing NAR with AR, the latter obtained
slightly better results (e.g. RMSE was 17.88 against
18.2 mg/dl, at 30 min horizon). This difference is even
more remarkable at 45 min horizons. On the other hand,
if we observe the values obtained with unfiltered train-
ing data, we can see the opposite (e.g. 25.96 mg/dl
against 24.66 mg/dl obtained by NAR at 30 min). Most
reasonably, NAR is more robust to non-linearities in the
training data when compared to AR. Nonetheless, if we
consider the overall figures of merit, the performance
of the two models in this specific application is almost
equivalent.
To perform a more in-depth analysis of the results,
in Figure 10, we show a plot of the RSME values obtained by
all the tested models, this time in %, reporting the prediction
horizon in the x-axis. To provide a better interpretation of the
obtained results, we highlighted in green the area of the plot
within a 20% RMSE range. In absence of clear indications by
past literature, we used this value as an indicative threshold
of acceptability for RMSE, consistent with the numerical
FIGURE 10. Overall RMSE comparison.
criteria for accuracy described by International Organisation
for Standardisation (ISO) [64], [65].
As it can be gathered from the plot, RSME consistently
increases with the prediction time, more or less with the
same slope for all models. The plot confirms the undisputed
superiority of LSTM,whichmaintained RSME values at least
10% better that all the other models, throughout all the tested
prediction horizons. On top of that, LSTM is the only one
that provided RMSE always within the 20% range, and below
15% up to a 60min prediction horizon. The behavior of NAR,
AR and RNN models do not have significant differences
for short-term predictions up to 30 min. The performance of
NAR gets worse after that, still maintaining just within the
acceptability range up to 60 min prediction horizon. AR and
RNN have a similar behavior up until the longest prediction
window, with slightly better performance for the AR model.
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TABLE 4. Overall Clarke error grid results.
As a qualitative confirmation of the good prediction accu-
racy of LSTM, in the following we show an example of
glucose predictions performed by this model, respectively
short-term (30 min) in Figure 11(a) and long-term (60 min)
in Figure 11(b). In both the plots, the predicted signal is
shown in blue, and the corresponding measured signal in red.
B. CLINICAL ASSESSMENT
Even though the metrics identified in Section IV-A are essen-
tial to understand the performance and prediction accuracy of
the different models from a regression analysis point of view,
they are not able to identify the most significant outliers, and
they do not provide any information about the clinical impact
of the prediction errors and of their consequences on medical
treatment decisions. Then, to provide amore thorough picture
of the models performance, we integrated our assessment
with Clarke Error Grid analysis (EGA) [66].
EGA is a semi-quantitative methodology introduced
in 1987 that is nowadays the most widely accepted tool for
the analysis of clinical accuracy of blood glucose estima-
tions. It provides a clinical interpretation of the mapping
between predicted and measured blood glucose levels, that
can be represented in a scatterplot with five main regions (see
Figure 12):
A: values within 20% of the reference;
B: values that, in spite of being outside 20% of the
reference, do not lead to inappropriate treatment of
the patient;
FIGURE 11. LSTM predictions at different forecasting horizons. (a) LSTM
prediction (30 min horizon). (b) LSTM prediction (60 min horizon).
C: values leading to inappropriate treatment, but with-
out dangerous consequences for the patient;
D: values leading to potentially dangerous failure to
detect hypoglycaemic or hyperglycaemic events;
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FIGURE 12. Clarke error grid analysis: Reference regions mapping.
E: values leading to treat hypoglycaemia instead of
hyperglycaemia and vice-versa.
Hence, zones A and B are the ones with full clinical accept-
ability. D and E, on the other hand, are the zones where
prediction errors are mostly dangerous for a patient [67].
The overall results of our Clarke Error Grid analysis are
reported in Table 4. More specifically, in each sub-section of
this table we report the EGA results of a tested model, with
our designed NAR and LSTM highlighted in grey and light
blue, respectively. As for the analytical assessment, different
columns of the table refer to different prediction horizons
(30 to 90 min, with steps of 15). Values in different rows
represent the percentage of values that fall within a specific
zone of the EGA map (A to E, respectively). Again, we show
for completeness the values obtained training the models on
raw and on filtered data, respectively.
From the analysis of Table 4, we can draw the following
considerations:
• The benefit of pre-processing the training data is again
confirmed by Clarke EGA, for all the tested models.
Hence, we will focus on these results.
• All the tested models had a satisfactory performance in
short-term predictions. More than 94% of the data in
the 30 min prediction horizon lay in the zone with best
clinical outcome A. When considering a medium-term
prediction horizon of 45 min, about 95% of the pre-
dictions fall within borders of the clinically acceptable
zones A and B. Consistently with analytical assessment,
the performance got worse when increasing further the
prediction horizon.
• Partially contradicting the outcome of the analytical
assessment, when considering the clinical outcome,
NAR model was outperformed by the other methods.
A possible interpretation of the discrepancy between
the analytical and the clinical assessments is that the
latter is much more affected by the presence of measure-
ment spikes and outliers. Hence, while other prediction
methods (and especially FNN) provide predictions that
are on average not well-correlated with the observed
measurements, they probably provided a lower num-
FIGURE 13. LSTM Clarke error grid analysis. (a) LSTM 30 min. (b) LSTM
60 min.
ber of outliers in comparison with NAR. Nonetheless,
as previously observed, the short-term prediction perfor-
mance of all the methods is quite comparable even from
a clinical point of view.
• The undisputed superiority of LSTM model, both for
short-term and long-term predictions, was confirmed
even by EGA results. This model maintained 99% of the
predicted values within the clinically acceptable zone up
to 60 min horizon window and more than 99% in zone
A up to 45 min forecasting. No other model showed
comparable performance.
To have a better view of LSTM performance, in Figure 13,
we show a graphical representation of LSTM EGA, respec-
tively for the short-term (30 min) predictions and the
long-term (60 min) predictions.
As it can be easily gathered from the plots, the data
in Figure 13(a) distribute along the bisector, which is the
region of highest correlation possible with the reference val-
ues. As expected, the data in Figure 13(b) have much higher
dispersion. Nonetheless, we can observe that, even though the
forecasting windowwas in this case extremely large (60min),
the wide majority of the values were still within the borders
of best clinical acceptability.
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V. CONCLUSIONS
In this work, we addressed the problem of automated glu-
cose level prediction leveraging multi-patient CGMS data.
Our specific aim is to learn a generalizable glucose level
prediction model from a multi-patient training set, using this
model to predict the future glucose values of a new patient.
This allows improving the usability of models that are solely
based on the past recordings of the same patient.
The main contribution of our work compared to past lit-
erature is two-fold: i) we learn the prediction models using
a large set of CMGS data from a very heterogeneous set of
diabetic patients. This possibly increases the generalization
capability of the model and minimizes the risks of overfit-
ting; ii) we design and compare different types of prediction
models, analyzing the prediction outcome both from the ana-
lytical and from the clinical point of view. To address the
limitations of literature approaches, we explored two types
of models. The first solution exploits a Non-Linear Autore-
gressive Neural Network (NAR), that is supposed to extend
the assumptions of linearity and overcome stability prob-
lems of traditional AR. The second solution exploits Long
Short-Term Memory (LSTM), that addresses the exploding
and vanishing gradient problems of classic RNN networks.
According to our experiments, the NAR network
obtained satisfactory results only for short-term predictions,
within 30 min. Nonetheless, if we take into account the
model’s simplicity (the NAR is based on just 8 regressors
against 30 of all the other approaches), which makes it
very convenient for hardware implementation, we can still
consider it a good solution for systems not requiring a very
large forecasting window.
Finally, as confirmed by both the analytical and clinical
assessment, our LSTM network overcame by far the predic-
tion accuracy of all the other models, for both short-term
and long-term predictions. Hence, we can conclude that
LSTM is the preferable approach for systems requiring a very
long-term forecasting window.
In our future work, we will extend our multi-patient data-
driven system by integrating real-time information. More
specifically, we plan to perform a real-time fine-tuning of
the model, leveraging the glucose level measurements of the
patient that is currently using the system.
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